Medicinal oils series | Soybean Oil | CP/USP | 8001-22-7 | CDE registration No.F20209990540,status “A” |
Medicinal oils series | Purified Olive Oil(For Injection) | USP/EP | 8001-25-0 | CDE registration No.Y20190000997,status “A” |
Medicinal oils series | Structured Triglyceride | Enterprise Standard | -- | R&D |
Medicinal oils series | Purified Fish Oil | USP/EP | 8016-13-5 | R&D |
Medicinal oils series | Sodium Oleate(For injection) | Enterprise Standard | 16558-02-4 | CDE registration No.F20220000120 |
Medicinal oils series | Soybean Oil for Injection | CP/USP/EP | 8001-22-7 | CDE registration No.Y20190000635,status “A” |
Medicinal oils series | Medium Chain Triglycerides | CP/USP/EP | 65381-09-1 | CDE registration No.Y20200001227,status “A” |
Medicinal Phospholipids series | Purified Egg lecithin / Egg Phospholipids | CP/USP/EP | 93685-90-6 | CDE registration No.F20190001049,status “A”,DMF#35483 |
Medicinal Phospholipids series | Egg Phosphatidyl Choline | CP | 93685-90-6 | CDE registration No.F20170000086,status “A” |
Medicinal Phospholipids series | Polyene Phosphatidyl Choline | Enterprise Standard | 8002-43-5 | R&D |
Medicinal Phospholipids series | Cholesterol(For injection) | CP | 57-88-5 | CDE registration No.F20170000625,status “A” |
Medicinal Phospholipids series | DSPE | Enterprise Standard | 1069-79-0 | R&D |
Medicinal Phospholipids series | DOPE | Enterprise Standard | 4004-05-1 | R&D |
Medicinal Phospholipids series | EPG | Enterprise Standard | 383907-64-0 | R&D |
Medicinal Phospholipids series | DSPC | Enterprise Standard | 816-94-4 | R&D |
Medicinal Phospholipids series | DOPC | Enterprise Standard | 4235-95-4 | R&D |
Medicinal Phospholipids series | Sphingomyelin/SM | Enterprise Standard | 383907-87-7 | R&D |
Medicinal Phospholipids series | DSPG-Na | Enterprise Standard | 200880-42-8 | R&D |
Medicinal Phospholipids series | DPPG-Na | Enterprise Standard | 67232-81-9 | R&D |
Oncology APIs | Vincristine Sulfate | CP/USP/EP/IP | 2068-78-2 | CDE registration No.Y20190009906,status “A”,DMF#18579 |
Oncology APIs | Vinblastine Sulfate | CP/USP/EP/IP | 143-67-9 | CDE registration No.Y20190007637,status “A” |
Oncology APIs | Vinorelbine Tartrate | CP/USP/EP/IP | 125317-39-7 | CDE registration No.Y20190006188,status “A”,DMF#25783 |
Oncology APIs | Vindesine Sulfate | CP/EP | 59917-39-4 | CDE registration No.Y20190007636,status “A” |
Cardiovascular APIs | Methyl Hesperidin | National Drug Standard | 11013-97-1 | CDE registration No.Y20190007574,status “A” |
Cardiovascular APIs | Tolperisone Hcl | National Drug Standard | 3644-61-9 | CDE registration No.Y20190008322,status “A” |
Cardiovascular APIs | Metoprolol Tartrate | CP | 56392-17-7 | CDE registration No.Y20190007575,status “A” |
Cardiovascular APIs | Trimetazidine Hcl | CP | 13171-25-0 | CDE registration No.Y20190007374,status “A” |
Anticholinergic APIs | Scopolamine Hydrobromide | CP | 114-49-8 | CDE registration No.Y20190001970,status “A” |
Anticholinergic APIs | Scopolamine Butylbromide | CP/EP | 149-64-4 | CDE registration No.Y20190007630,status “A” |
Others | Propyl Gallate | CP/USP/EP | 121-79-9 | CDE registration No.Y20190007577,status “A” |
Others | Bifonazole | CP | 60628-96-8 | CDE registration No.Y20190007629,status “A” |
Others | Clotrimazole | CP | 23593-75-1 | CDE registration No.Y20190007626,status “A” |
Functional additive | Eggyolk oil | Enterprise Standard | 8001-17-0 | -- |
Functional additive | Egg Protein Powder | Enterprise Standard | -- | -- |